What’s Up With U.S. Merger Remedies?
February 26, 2024
ABA Our Curious Amalgam
Axinn managing partner Jeny Maier co-hosted ABA's Our Curious Amalgam podcast in an episode entitled, "What’s Up With U.S. Merger Remedies?"
Jeny spoke with Dan Ducore, former Assistant Director of the Federal Trade Commission’s Bureau of Competition Compliance Division, to discuss the growing skepticism towards merger remedies by the U.S. antitrust authorities.
Click here to access the episode.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
